FrancophonIA/ELRC3.0 huggingface dataset:
English: A booster vaccination with a 7.5 µg heterologous A/Indonesia/05/2005 vaccine strain has been administered in a time window of 12 to 24 months after priming vaccination with two doses of the A/Vietnam/1203/2004 strain vaccine in three clinical studies in adults aged 18 to 59 years and in older people aged 60 years and above.
Danish: En boostervaccination med en 7,5 µg heterolog A/Indonesien/05/2005-stamme er blevet administreret over en tidsperiode på 12 til 24 måneder efter indledende vaccination med to doser af A/Vietnam/1203/2004-stammen i tre kliniske studier hos voksne i alderen 18 til 59 år og ældre personer på 60 og derover.
English: After primary vaccination the seroprotection rate, seroconversion rate and seroconversion factor for anti-HA antibody as measured by single radial haemolysis (SRH) in adults aged 18 to 59 years and in older subjects aged 60 years and above were as follows:
Danish: Efter primær vaccination var seroprotektionsværdi, serokonversionsværdi og serokonversionsfaktor for anti-HA-antistof, målt med enkelt radial hæmolyse (SRH) hos voksne fra 18 til 59 år og ældre personer på 60 år og derover som følger:
English: * SRH area ≥ 25 mm²
Danish: 12 måneders booster * SRH-område ≥ 25 mm²
English: Very Common Very Common
Danish: Almindelig Meget almindelig
English: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER should not be given at the same time as other vaccines.
Danish: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER må ikke gives på samme tid som andre vacciner.
English: Injections of PANDEMIC INFLUENZA VACCINE H5N1 BAXTER and immunoglobulin should be made into separate limbs.
Danish: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER og immunoglobulin bør injiceres i hver sin ekstremitet.
English: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER may be used in lactating women.
Danish: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER kan anvendes under amning.
English: • vertigo (a spinning sensation)
Danish: • følelse af at det drejer rundt (vertigo)
English: * SRH area ≥ 25 mm² ** either SRH area ≥ 25 mm if baseline sample negative or 50% increase in SRH area if baseline sample > 4 mm² *** geometric mean increase
Danish: Serokonversionsfaktor*** * SRH-område ≥ 25 mm ** enten SRH-område ≥ 25 mm2 hvis basislinje-prøven er negativ eller 50 % stigning i SRH område, hvis basislinje-prøven > 4 mm *** geometrisk middelstigning
English: • PANDEMIC INFLUENZA VACCINE H5N1 BAXTER should not be given at the same time as other vaccines.
Danish: • PANDEMIC INFLUENZA VACCINE H5N1 BAXTER må ikke gives samtidig med andre vacciner.
English: • swollen glands
Danish: • hævede kirtler
English: An overview for all spontaneous adverse reactions by SOC, High Level Term (HLT) and Preferred Term (PT), stratified according to type of report (medically confirmed or non-medically confirmed) and including the number of fatal reports, for the period covered by the report and cumulatively.
Danish: En oversigt over alle spontane reaktioner efter organklasser, Højt Niveau Term (HNT) og Foretrukket Term (FT), opdelt efter rapporttype (medicinsk bekræftet eller ikke-medicinsk bekræftet) og omfattende antallet af dødsfald rapporteret i perioden, som dækkes af rapporten, og kumuleret.
English: Irritability Malaise Feeling Cold
Danish: Kuldegysninger Irritabilitet Ubehag
English: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER suspension for injection Pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)
Danish: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER injektionsvæske, suspension Pandemisk influenzavaccine (H5N1) (hel virion, inaktiveret, fremstillet i cellekultur)
English: NAME OF THE MEDICINAL PRODUCT PANDEMIC INFLUENZA VACCINE H5N1 BAXTER Suspension for injection
Danish: PANDEMIC INFLUENZA VACCINE H5N1 BAXTER injektionsvæske, suspension
English: After primary vaccination the rate of subjects with neutralising antibody titres ≥ 20, seroconversion rate and seroconversion factor as measured by microneutralisation assay (MN) in adults aged 18 to 59 years and in older subjects aged 60 years and above were as follows:
Danish: Efter primær vaccination var tallene for personer med neutraliserende antistoftitre > 20, serokonversionsværdi og serokonversionsfaktor, målt med mikroneutraliseringsanalyse (MN) hos voksne fra 18 til 59 år og ældre personer på 60 år og derover, som følger:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Influenza vaccine (whole virion, inactivated) containing antigen * of: A/Vietnam/1203/2004 (H5N1)
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Influenzavaccine,(hel virion, inaktiveret) indeholdende antigen*: A/Vietnam/1203/2004 (H5N1)
English: All spontaneous adverse reactions (SOC, HLT, PT) occurring in pregnant women, stratified according to type of report (medically confirmed or non-medically confirmed), for the period covered by the report and cumulatively.
Danish: Alle spontane reaktioner (SOC, HNT, FT), som forekommer hos gravide kvinder, opdelt efter rapporttype (medicinsk bekræftet eller ikke-medicinsk bekræftet), for perioden, som dækkes af rapporten, og kumuleret.
English: • eye irritation
Danish: • øjenirritation
English: Do not use PANDEMIC INFLUENZA VACCINE H5N1 BAXTER
Danish: Du må ikke få PANDEMIC INFLUENZA VACCINE H5N1 BAXTER
English: A heterologous booster vaccination with a 7.5 µg non-adjuvanted formulation of the A/Indonesia/05/2005 strain vaccine has been administered 12 months after a priming vaccination with two doses of the A/Vietnam/1203/2004 strain vaccine in children and adolescents aged 9 to 17 years (N=196), children aged 3 to 8 years (N=79) and infants and children aged 6 months to 35 months (N=25).
Danish: En heterolog boostervaccination med en 7,5 µg ikke-adjuveret formulering af A/Indonesia/05/2005-stammen er blevet administreret til børn og unge i alderen fra 9 til 17 år (N=196), børn i alderen fra 3 til 8 år (N=79) og spædbørn og børn i alderen fra 6 måneder til 35 måneder (N=25) 12 måneder efter en indledende vaccination med to doser af vaccine med A/Vietnam/1203/2004-stammen.
English: - Anaphylaxis:
Danish: - Anafylaksi:
English: However, if co-administration with another vaccine is indicated, immunisation should be carried out on separate limbs.
Danish: Hvis det er nødvendigt med samtidig indgift af andre vacciner, skal dette ske i forskellige ekstremiteter.
English: Serious unlisted adverse reactions (SOC, HLT, PTs) stratified according to type of report (medically confirmed or non-medically confirmed), for the period covered by the report and cumulatively.
Danish: Alvorlige, uventede reaktioner (SOC, HNT, FT'er), opdelt efter rapporttype (medicinsk bekræftet eller ikke-medicinsk bekræftet) for perioden, som dækkes af rapporten, og kumuleret.
English: Diarrhea Vomiting Nausea
Danish: MAVE-TARM-KANALEN Diarré Kvalme
English: After vaccination, the seroprotection rate, seroconversion rate, and seroconversion factor for anti-HA antibody, as measured by SRH, in, infants, children, and adolescents aged 6 months to 17 years were as follows:
Danish: Efter vaccination var seroprotektionsværdi, serokonversionsværdi og serokonversionsfaktor for anti-HA-antistof, målt med enkelt radial hæmolyse (SRH), hos spædbørn, børn og unge i alderen fra 6 måneder til 17 år som følger:
English: The protective efficacy of PANDEMIC INFLUENZA VACCINE H5N1 BAXTER against morbidity and mortality induced by the infection with lethal doses of highly pathogenic avian Influenza
Danish: Den beskyttende virkning af PANDEMIC INFLUENZA VACCINE H5N1 BAXTER mod sygdom og død påført af en infektion med dødelige doser af en svært patogen aviær Influenza H5N1-virus er blevet evalueret præklinisk i en undersøgelse, hvor et antal fritter blev udsat for virusangreb.
English: Fatigue Pyrexia Chills
Danish: Træthed Pyreksi
English: All spontaneous adverse reactions by age group, per SOC, HLT and PT, stratified according to type of report (medically confirmed or non-medically confirmed), for the period covered by the report and cumulatively.
Danish: Alle spontane reaktioner opdelt efter aldersgruppe, per SOC, HNT og FT og efter rapporttype (medicinsk bekræftet eller ikke-medicinsk bekræftet), for perioden, som dækkes af rapporten, og kumuleret.
English: Detailed information on this medicine is available on the European Medicines Agency (EMA) web site: http://www.ema.europa.eu/
Danish: Du kan finde yderligere oplysninger om PANDEMIC INFLUENZA VACCINE H5N1 BAXTER på Det Europæiske Lægemiddelagenturs hjemmeside: http://www.ema.europa.eu/
English: 6.5 Nature and contents of the container
Danish: 6.5 Emballagetype og pakningsstørrelser
English: Cough
Danish: Batch
English: After vaccination, the rate of subjects with neutralizing antibody titers ≥ 20, seroconversion rate and seroconversion factor, as measured by MN assay, in infants, children, and adolescents aged 6 months to 17 years were as follows:
Danish: Efter vaccination var andelen af personer med neutraliserende antistoftitre ≥ 20, serokonversionsværdi og serokonversionsfaktor, målt med mikroneutraliseringsanalyse (MN), hos spædbørn, børn og unge i alderen fra 6 måneder til 17 år som følger:
English: Whole virion H5N1 influenza vaccine, inactivated, containing antigen of*: A/Vietnam/1203/2004 (H5N1)
Danish: Influenzavaccine, hel virion H5N1, inaktiveret indeholdende antigen*: A/Vietnam/1203/2004 (H5N1)
English: • Injection site pruritus
Danish: • Pruritus
English: Seroneutralisation rate**
Danish: Serokonversionsværdi**
English: • There are no data with PANDEMIC INFLUENZA VACCINE H5N1 BAXTER using the subcutaneous route.
Danish: • Der foreligger ingen data om subkutan brug af PANDEMIC INFLUENZA VACCINE H5N1 BAXTER.
English: Seroprotection rates (SRH area ≥ 25 mm²) at 21 days after a 12 months booster vaccination with the 7.5 µg dose of the A/Indonesia/05/2005 strain vaccine, tested against both the homologous and heterologous strains, were as follows:
Danish: Seroprotektionsværdier (SRH-område ≥ 25 mm²) 21 dage efter en 12 måneders boostervaccination med en 7,5 µg dosis af A/Indonesia/05/2005-stammen, testet imod både de homologe og heterologe stammer, var som følger:
English: Injection site pruritus Axillary pain
Danish: Pruritus på injektionsstedet Skuldersmerter
English: ** either SRH area ≥ 25 mm2 if baseline sample negative or 50% increase in SRH area if baseline sample >4 mm² *** geometric mean increase
Danish: Serokonversionsfaktor*** * SRH-område ≥ 25 mm2 ** enten SRH-område ≥ 25 mm2, hvis basislinje-prøven er negativ, eller 50 % stigning i SRH-område, hvis basislinje-prøven > 4 mm2 *** geometrisk middelstigning
English: Seroneutralisation rates (MN titre ≥ 20) at 21 days after a 12 to 24 months booster vaccination with the 7.5 µg dose of the A/Indonesia/05/2005 strain vaccine, tested against both the homologous and heterologous strains were as follows:
Danish: Seroneutraliseringsværdier (MN-titer ≥ 20) 21 dage efter en 12-24 måneders boostervaccination med en 7,5 µg dosis af A/Indonesien/05/2005-stammen testet imod både de homologe og heterologe stammer var følgende:
English: Other medicines and PANDEMIC INFLUENZA VACCINE H5N1 BAXTER
Danish: Brug af anden medicin sammen med PANDEMIC INFLUENZA VACCINE H5N1 BAXTER
English: STATEMENT OF ACTIVE SUBSTANCE(S) Influenza vaccine (whole virion, inactivated) containing antigen of*: A/Vietnam/1203/2004 (H5N1)
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Influenzavaccine (hel virion, inaktiveret) der indeholder antigen*: A/Vietnam/1203/2004 (H5N1)
English: After vaccination the rate of subjects with neutralising antibody titres ≥ 20, seroconversion rate and seroconversion factor as measured by MN assay in immunocompromised subjects and patients with chronic disease conditions were as follows:
Danish: serokonversionsværdien og serokonversionsfaktoren, målt med mikroneutraliseringsanalyse (MN) hos immunkompromitterede personer og patienter med kroniske sygdomme følgende:
English: Hypotension
Danish: Hypæstesi
English: • malaise
Danish: • Irritation
English: For PANDEMIC INFLUENZA VACCINE H5N1 BAXTER post-marketing surveillance data are not yet available.
Danish: Der foreligger endnu ingen data fra bivirkningsovervågning efter markedsføring af PANDEMIC INFLUENZA VACCINE H5N1 BAXTER.
English: • hardness, redness or swelling at the injection site
Danish: • hårdhed, rødme eller hævelse på injektionsstedet
English: Very common Common Common Common Common
Danish: Almindelig Almindelig Almindelig Almindelig
English: Very common Uncommon Uncommon Common
Danish: Meget almindelig Ikke almindelig Ikke almindelig Almindelig
English: Common Very Common
Danish: Meget almindelig
English: • if you have had any allergic reaction, to any ingredient contained in the vaccine (see section 6 at the end of the leaflet) or to formaldehyde, benzonase or sucrose.
Danish: 6 til sidst i indlægssedlen) eller over for formaldehyd, benzonase eller saccharose.
English: • fits
Danish: • kløe
English: Seroneutralization rates (MN titer ≥ 20) at 21 days after a booster vaccination with the 7.5 µg dose of the A/Indonesia/05/2005 strain vaccine, tested against both the homologous and heterologous strains, were as follows:
Danish: Seroneutraliseringsværdier (MN titer ≥ 20) 21 dage efter en boostervaccination med en 7,5 µg dosis af A/Indonesia/05/2005-stammen, testet imod både de homologe og heterologe stammer, var som følger: Seroneutraliseringsværdi*
English: Infants, children and adolescents: Adverse Reactions (Infants, Children and Adolescents)
Danish: Bivirkninger (spædbørn, børn og unge) Systemorganklasse Foretrukken MedDRA-term
English: Oropharyngeal pain Rhinorrhoea
Danish: Orofaryngeal smerte Hoste
English: After removing the syringe cap, attach the needle immediately and remove the needle shield prior to administration.
Danish: Nålebeskyttelsen fjernes før administration.
English: History of an anaphylactic (i.e. life-threatening) reaction to the active substance, to any of the excipients listed in section 6.1 or to trace residues (e.g. formaldehyde, benzonase, sucrose) of this vaccine.
Danish: Tidligere anafylaktisk reaktion (dvs. livstruende) over for det aktive stof, et eller flere af hjælpestofferne anført i pkt.
English: • Injection site induration
Danish: • Induration
English: VASCULAR DISORDERS
Danish: VASKULÆRE SYGDOMME
English: Very Common Common Common Common Common Uncommon Uncommon Uncommon
Danish: Meget almindelig Almindelig Almindelig Almindelig Almindelig Ikke almindelig Ikke almindelig Ikke almindelig
English: Common (≥1/100 to <1/10)
Danish: Meget almindelig (≥1/10) Almindelig (≥1/100 til <1/10) Ikke almindelig (≥1/1.000 til <1/100)
English: • vomiting, feeling sick, diarrhoea
Danish: • udslæt, nældefeber
English: Heterologous Booster Vaccinations
Danish: VASKULÆRE SYGDOMME Hypotension
English: • vertigo (motion sickness)
Danish: • følelse af at dreje rundt (søsyge/køresyge)
English: • stuffy or runny nose
Danish: Tilstoppet næse Rinorré
English: How PANDEMIC INFLUENZA VACCINE H5N1 BAXTER is given Possible side effects
Danish: Sådan får du PANDEMIC INFLUENZA VACCINE H5N1 BAXTER Bivirkninger
English: Very Common Common Common Common Uncommon Uncommon
Danish: Meget almindelig Almindelig Almindelig Almindelig Ikke almindelig Ikke almindelig
English: narrow SMQ “Convulsions”
Danish: snæver Standardiseret MedDRA Forespørgsel (SMF) ”Kramper”
English: MARKETING AUTHORISATION NUMBER(S) EU/1/09/571/002
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/09/571/002
English: MARKETING AUTHORISATION NUMBER(S) EU/1/09/571/001
Danish: MARKEDSFØRINGSTILLADELSESNUMMER(-NUMRE) EU/1/09/571/001
English: Lymphadenopathy
Danish: • mavesmerter
English: Antibody persistence
Danish: Antistofpersistens
English: MARKETING AUTHORISATION NUMBER EU/1/09/571/001
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/09/571/001
English: Chills
Danish: SRH-ananlyse
English: • Injection site movement impairment
Danish: • Nedsat bevægelighed ved injektionsstedet
English: Revaccination: every year.
Danish: Revaccination: hvert år
English: The reaction was transient
Danish: Reaktionen var forbigående.
English: ATC Vet code: QI06AJ02
Danish: ATC Vet kode: QI06AJ02
English: This vaccine should not be handled by persons who are immunodeficient or taking immunosuppressive medicinal products.
Danish: Denne vaccine bør ikke håndteres af personer, der er immundeficiente eller tager immunsuppressive lægemidler.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/
Danish: Nærmere oplysninger om dette veterinærlægemiddel er tilgængelige på webstedet for Det Europæiske Lægemiddelagentur (EMEA) http://www.emea.europa.eu/
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23/02/2005
Danish: DATO FOR FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN Dato for første tilladelse: 23/02/2005
English: The duration of immunity is 1 year after the last (re-)vaccination.
Danish: Varigheden af immunitet er 1 år efter sidste (re-)vaccination.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/04/049/001-002
Danish: MARKEDSFØRINGSTILLADELSENS NUMMER (NUMRE) EU/2/04/049/001-002
English: Date of last renewal: 15/01/2010
Danish: Dato for fornyelse af tilladelsen: 15/01/2010
English: 69800 SAINT-PRIEST France
Danish: 69800 Saint-Priest
English: In exceptional circumstances a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.
Danish: I yderst sjældne tilfælde kan hypersensitivitetsreaktion forekomme, der kan kræve korrekt symptomatisk behandling.
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary No effect other than those already mentioned in section 4.6 “Adverse reactions” have been observed, except hyperthermia that may exceptionally last 5 days.
Danish: 4.10 Overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt Der er ikke iagttaget andre symptomer end de, der er nævnt under punkt 4.6 ”Bivirkninger”, bortset fra hyperthermi, der i sjældne tilfælde kan vare op til 5 dage.
English: 1: cell culture infective dose 50% 2: egg infective dose 50%
Danish: 1: cellekultur infektiøs dosis 50% 2: æg infektiøs dosis 50%
English: The reaction was transient If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
Danish: Hvis De bemærker alvorlige bivirkninger eller andre bivirkninger, som ikke er omtalt i denne indlægsseddel, bedes De kontakte Deres dyrlæge.
English: In normal conditions of use, transient apathy and anorexia may occasionally occur, as well as hyperthermia (lasting usually for 1 or 2 days).
Danish: Under normale omstændigheder kan der af og til forekomme apati og anoreksi samt hyperthermi (der sædvanligvis varer 1 til 2 dage).
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING 1 dosis (1 ml) indeholder:
English: EU/2/04/049/001 Lyophilisate (10 bottles of 1 dose) + solvent (10 bottles of 1 ml) EU/2/04/049/002 Lyophilisate (50 bottles of 1 dose) + solvent (50 bottles of 1 ml)
Danish: EU/2/04/049/001 Lyofilisat (10 flasker à 1 dosis) + solvens (10 flasker à 1 ml) EU/2/04/049/002 Lyofilisat (50 flasker à 1 dosis) + solvens (50 flasker à 1 ml)
English: In very rare cases, hyperthermia and lethargy sometimes associated with lameness has been observed one to three weeks following booster vaccination in adult cats.
Danish: Hyperthermi og letargi, der sommetider er forbundet med halthed, er i meget sjældne tilfælde observeret én til tre uger efter revaccination af voksne katte.
English: Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest France
Danish: Laboratoires Porte des Alpes Rue de l'Aviation F-69800 SAINT-PRIEST FRANKRIG
English: If self-injection occurs, immediate medical advice should be sought and the doctor informed that self-injection with a living chlamydial vaccine has occurred.
Danish: Hvis selvinjektion opstår ved et uheld, bør der øjeblikkeligt søges læge og lægen informeres om, at selvinjektion med en levende chlamydia vaccine er sket.
English: SPECIAL STORAGE CONDITIONS Store and transport refrigerated (2 °C - 8 °C) Protect from light.
Danish: SÆRLIGE OPBEVARINGSBETINGELSER Opbevares og transporteres nedkølet (2°C - 8°C).
English: CONTRAINDICATIONS Do not use in pregnant animals.
Danish: KONTRAINDIKATIONER Skal ikke anvendes til drægtige dyr.
English: Where high levels of maternal antibodies against R, C or Ch components are expected to be present (e.g. in kittens of 9-12 weeks of age born from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
Danish: Ved mistanke om tilstedeværelse af høje værdier af maternelle antistoffer over for R-, C- eller Chkomponenterne (fx hos 9-12 uger gamle killinger født af hunkatte, der var vaccineret før drægtighed, og/eller ved kendskab til eller mistanke om, at moderdyret har været udsat for de pågældende patogener), bør basisvaccination udsættes til killingerne er 12 uger gamle.
English: Manufacturer for the batch release: MERIAL
Danish: Ansvarlig for batchfrigivelse: MERIAL
English: Primary vaccination course: - first injection: from 8 weeks of age, - second injection: 3 to 4 weeks later.
Danish: • anden injektion: 3-4 uger senere.
English: Type I glass bottle containing 1 dose of lyophilisate and type I glass bottle containing 1 ml of solvent, both closed with a butyl elastomer closure and sealed with an aluminium cap.
Danish: Type I glasflaske indeholdende 1 dosis af lyofilisat og type I glasflaske indeholdende 1 ml solvens, begge lukket med en butyl elastomer prop og forseglet med en aluminiumskapsel.
English: Store and transport refrigerated (2 °C - 8 °C) Protect from light.
Danish: Opbevares og transporteres nedkølet (2°C - 8°C).
English: Name and address of the manufacturer(s) of the biological active substance(s)
Danish: Navn og adresse på fremstiller(e) af de(t) biologisk aktive stof(fer) Merial
English: Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) ...................................... ≥ 104.9 CCID50 Inactivated feline Calicivirosis antigens (FCV 431 and FCV G1 strains) ..................... ≥ 2.0 ELISA U. Attenuated Chlamydophila felis (905 strain) .................................................................... ≥ 103.0 EID50 Excipient:
Danish: Svækket felin rhinotracheitis herpesvirus (FHV F2 stamme) .......................................... >104,9 CCID50 Dræbte feline calicivirose antigener (FCV 431 og G1 stammer) .................................... >2.0 ELISA U. Svækket Chlamydophila felis (905 stamme) .................................................................... >103,0 EID50 Hjælpestoffer:
English: Per dose of 1ml: FHV (F2 strain) ................................................................................................................. ≥ 104.9 CCID50
Danish: 1 dosis (1 ml) indeholder: FHV (F2 stamme) ............................................................................................................... >104,9 CCID50
English: Lyophilisate (10 bottles of 1 dose) + solvent (10 bottles of 1 ml) Lyophilisate (50 bottles of 1 dose) + solvent (50 bottles of 1 ml)
Danish: Lyofilisat (10 flasker à 1 dosis) + solvens (10 flasker à 1 ml) Lyofilisat (50 flasker à 1 dosis) + solvens (50 flasker à 1 ml)
English: Vaccine against feline viral rhinotracheitis, feline calicivirosis and chlamydiosis.
Danish: Vaccine mod felin viral rhinotracheitis, felin calicivirose og chlamydiose.
English: Gentamicin, at most.......................................................................................................................... 28 µg Solvent:
Danish: Gentamycin max…………………………………………………………….....................……………….….. 28 µg Solvens:
English: WITHDRAWAL PERIOD
Danish: UDLØBSDATO
English: Shelf life of the veterinary medicinal product as packaged for sale:18 months.
Danish: Opbevaringstid for veterinærlægemidlet i salgspakning: 18 måneder Opbevaringstid efter rekonstitution: anvendes umiddelbart efter rekonstitution.